BioSpace News Archive

Mevion Medical Systems and Orfit Industries are pleased to announce that the Aerial® Couch Top is validated for use on the MEVION S250® Series Proton Therapy Systems.

Voclosporin ophthalmic solution (VOS) results anticipated in the fourth quarter of 2020

Chinese biologic drug developer SinocellTech, Qiming’s portfolio company, lands on the Science and Technology Innovation Board.

Arçelik, which owns Beko and Grundig, collaborated with leading Turkish businesses to produce the life-saving ventilators on a not-for-profit basis

G1 Therapeutics, Inc. and Genor Biopharma Co. Inc. announced an exclusive license agreement for the development and commercialization of lerociclib in the Asia-Pacific region.

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced it has resumed in-person patient visits for casting, fitting and delivering its MyoPro® powered braces in states that are now allowing such interactions.

Evelo Biosciences, Inc. a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologic therapies, announced that EDP1815 will be included in the TACTIC-E clinical trial.

FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide (PEA), or FSD201. This single-site study was conducted at the Alf

Phase 1 portion of the Phase 1/2a trial, 48 healthy volunteers were treated with either single or multiple weekly dose regimens

The McGill University Health Centre Foundation is proud to announce a personal donation of $100,000 from Marc Parent, President and CEO of CAE and MUHC Foundation board member.